The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective analysis of neoadjuvant chemoradiotherapy for esophageal cancer: The Knight Cancer Institute experience.
Faisal A Siddiqui
No relevant relationships to disclose
James P. Dolan
No relevant relationships to disclose
John G. Hunter
No relevant relationships to disclose
Miriam A. Douthit
No relevant relationships to disclose
Lisa M. Bloker
No relevant relationships to disclose
John M Holland
No relevant relationships to disclose
Charles R. Thomas
No relevant relationships to disclose